William H. Bestermann, Jr., MD
William H. Bestermann Jr., MD is a board-certified internist who practiced preventive cardiology for 20 years. He has been heavily involved with health care reform and quality improvement during that same period. He wrote the first article on a systematic approach to the metabolic syndrome. He led an advanced cardiometabolic medical home that managed high-risk diabetic and hypertensive patients for a Fortune 100 company in Tennessee. He is a Senior Clinical Advisor for the Quality Blue Primary Care program at Blue Cross Blue Shield of Louisiana. That initiative saved $27 pmpm net at the 18 month mark while reducing hospitalizations, length of stay, and specialty referrals. He is currently the Chief Medical Officer at Epigenex Health Inc.
Healthy Life Extended by Eight Years in a Landmark Study
We know we can extend healthy life using readily available medications and a team-based, systematic approach. But, do we have the will to do it?
Erectile Dysfunction: Is It a Sign of Heart Disease?
Erectile dysfunction may be an early warning sign of arterial disease because the health of the penile arteries reflects the health of the rest of the arteries as well.
Is There Really a Way to Reverse Diabetes?
High glucose levels found in people with Type 2 diabetes are only one part of the complex molecular biology that causes diabetic complications. Lowering glucose levels without addressing the other issues will not prevent cardiovascular complications.
An Election Day Reminder: Vote Like Your Life Depends On It
Politicians are fanning the dark side in America giving rise to entrenched divisions. But pulling away to our corners while insulting, demonizing, and dehumanizing people who look or think differently is a formula for national disaster.
A Unifying Hypothesis of Chronic Disease and Aging
Accelerated aging and disease in the skin are largely driven by excess oxidative particles generated by sun exposure and other environmental factors.
How to Achieve High Value from your Executive Health Program
Executive health programs often include interventions that are high cost, low efficacy or both including screening tests offer no value & may even cause harm.
Why We Need to Unlock the Full Potential of Primary Care
Primary care 3.0 focuses on molecular medical management that prevents & effectively treats chronic conditions & slows aging. Everyone should have access to it.
The ACCORD Trial: Is Aggressive Glucose Lowering Finished?
Glucose lowering, per se, does not prevent heart attack, stroke, or death. The message to take away from the ACCORD shut-down is that aggressive treatment is a bad idea.
New Technology to Determine Risk of Heart Attack
Dr. Bestermann explains the extensive literature on the new science of risk assessment and the importance of vulnerable plaque.
Sudden Death: When Will We Finally Do What Needs to be Done?
In 1988, Dr. WC Little wrote that bypass surgery and angioplasty could not be expected to prevent heart attack in stable patients. He predicted the results of the landmark COURAGE trial 20 years ahead of time.
Type 2 Diabetes Treatment Made Easy
Most type 2 diabetics have been resistant to the effects of insulin and metabolically abnormal for years prior to developing full-blown diabetes.
The Cardiometabolic Syndrome is a Complex Metabolic Web
The underpinning for much of the death and disability from arterial vascular disease in this country is the metabolic syndrome.